Showing results (61-70 of 94) with videos related to
Sort By:
Pageof 10
Nephron. Physiology|July 12, 2007
Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 miceRyan M Fryer, Pamela A Rakestraw, Masaki Nakane, et al.American Journal of Physiology. Heart and Circulatory Physiology|November 6, 2007
Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogsPatricia N Banfor, Lee C Preusser, Thomas J Campbell, et al.Clinical and Experimental Pharmacology & Physiology|February 1, 2006
Effects of intravenous ABT-870 (iron (III)-hydroxide oligosaccharide) on mean arterial pressure and heart rate in the anaesthetized beagle: comparison with other iron-containing haematinic agentsLee C Preusser, Ryan M Fryer, Armin Gerhardt, et al.International Journal of Environmental Research and Public Health|April 25, 2020
A Metabolically Healthy Profile Is a Transient Stage When Exercise and Diet Are Not Supervised: Long-Term Effects in the EXERDIET-HTA StudyPablo Corres, Simon M Fryer, Aitor Martínez Aguirre-Betolaza, et al.The Journal of Pharmacology and Experimental Therapeutics|May 25, 2023
Soluble Guanylyl Cyclase Activator BI 685509 Reduces Portal Hypertension and Portosystemic Shunting in a Rat Thioacetamide-Induced Cirrhosis ModelAmanda K Jones, Hongxing Chen, Khing Jow Ng, et al.Scandinavian Journal of Clinical and Laboratory Investigation|November 27, 2018
Is cardiorespiratory fitness independently associated with the biochemical profile in overweight/obese adults with primary hypertension? The EXERDIET-HTA studyPablo Corres, Sara Maldonado-Martín, Ilargi Gorostegi-Anduaga, et al.Journal of Cardiovascular Pharmacology|July 10, 2004
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canineRyan M Fryer, Lee C Preusser, Samuel V Calzadilla, et al.Journal of Cardiovascular Pharmacology|February 4, 2009
ETA receptor blockade with atrasentan prevents hypertension with the multitargeted tyrosine kinase inhibitor ABT-869 in telemetry-instrumented ratsPatricia N Banfor, Pamela A Franklin, Jason A Segreti, et al.Journal of Cardiovascular Pharmacology|December 20, 2011
Strategic integration of in vivo cardiovascular models during lead optimization: predictive value of 4 models independent of species, route of administration, and influence of anesthesiaRyan M Fryer, Paul C Harrison, Akalushi Muthukumarana, et al.The Journal of Pharmacology and Experimental Therapeutics|July 20, 2007
Systemic activation of the calcium sensing receptor produces acute effects on vascular tone and circulatory function in uremic and normal rats: focus on central versus peripheral control of vascular tone and blood pressure by cinacalcetRyan M Fryer, Jason A Segreti, Deborah L Widomski, et al.Pageof 10